---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40143391.md"
description: "$Hims & Hers Health(HIMS.US)There's still a 200EMA overhead. If it can officially break through and clean up the resistance above, it's not far from a real rally.Today's announcement that it can sell Eli Lilly's products means the company has officially abandoned the compound drug of GLP-1. Compliance is the only right path for a pharmaceutical company. Looking back at the recent garbage time was still quite agonizing. Let's see if there are any related follow-up news; I'm quite interested in their recent wave of important decisions."
datetime: "2026-04-23T14:51:50.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40143391.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40143391.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40143391.md)
author: "[OrangeToast](https://longbridge.com/en/profiles/13875818.md)"
---

# $Hims & Hers Health(HIMS.US)There's still a 20…


### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)